S
Setareh Moghimi
Researcher at Tehran University of Medical Sciences
Publications - 91
Citations - 1155
Setareh Moghimi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 15, co-authored 79 publications receiving 726 citations. Previous affiliations of Setareh Moghimi include Alzahra University & University of Tehran.
Papers
More filters
Journal ArticleDOI
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy.
Adileh Ayati,Setareh Moghimi,Somayeh Salarinejad,Maliheh Safavi,Behjat Pouramiri,Alireza Foroumadi +5 more
TL;DR: The recent advances on the discovery and development of different EGFR inhibitors and the use of various therapeutic strategies such as multi-targeting agents and combination therapies have also been reviewed.
Journal ArticleDOI
Thiazole in the targeted anticancer drug discovery.
TL;DR: This review provides an overview of recent advances in thiazole-bearing compounds as anticancer agents with particular emphasis on their mechanism of action in cancerous cells.
Journal ArticleDOI
Transition‐Metal‐Catalyzed Acyloxylation: Activation of C(sp2)–H and C(sp3)–H Bonds
TL;DR: In this article, a review of recent advances in C-H bond activation for transition-metal-catalyzed acyloxylation is presented, with the emphasis on the role of directing groups in these transformations.
Journal ArticleDOI
An efficient synthesis of thiazol-2-imine derivatives via a one-pot, three-component reaction
Majid M. Heravi,Setareh Moghimi +1 more
TL;DR: In this article, a simple and highly efficient one-pot, three-component procedure for the synthesis of thiazol-2-imines, via the reaction of aromatic α-bromoketones, primary amines, and phenyl isothiocyanate in the presence of a catalytic amount of triethylamine, is described.
Journal ArticleDOI
Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
Adileh Ayati,Tayebeh Oghabi Bakhshaiesh,Setareh Moghimi,Rezvan Esmaeili,Keivan Majidzadeh-A,Maliheh Safavi,Loghman Firoozpour,Saeed Emami,Alireza Foroumadi +8 more
TL;DR: Investigation by flow cytometric analysis confirmed that the 2-thiomorpholinothiazole derivative 3k induces apoptotic cell death in MCF-7 cells and cause G1-phase arrest in the cell cycle.